Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Neoadjuvant giredestrant plus palbociclib (P) vs. anastrozole (A) plus P in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+, HER2-eBC): Patient (pt)-reported outcomes (PROs) in the randomized, open-label, international phase II coopERA BC study
- Authors
- Park, YH[Park, Yeon Hee]; Quiroga, V[Quiroga, Vanesa]; Fasching, PA[Fasching, Peter A.]; Bardia, A[Bardia, Aditya]; Lopez-Valverde, V[Lopez-Valverde, Vanesa]; Crnjevic, TB[Crnjevic, Tanja Badovinac]; Steinseifer, J[Steinseifer, Jutta]; Devine, J[Devine, Jacob]; Hurvitz, SA[Hurvitz, Sara A.]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.